ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2017 ACR/ARHP Annual Meeting

November 3-8, 2017. San Diego, CA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
  • Abstract Number: 1335
    p62/SQSTM1 Modulates Bone Erosions in a Murine Model of Rheumatoid Arthritis
  • Abstract Number: 186
    Paediatric Musculoskeletal (MSK) Triage in the Community – Rightpath – a Pilot Study
  • Abstract Number: 2849
    Pain and Functional Trajectories in Symptomatic Knee Osteoarthritis over a 12-Week Period of Non-Pharmacological Exercise Interventions
  • Abstract Number: 316
    Pain, Fatigue and Function in Patients with Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder – Relationship with Perceived Benefits and Barriers to Exercise
  • Abstract Number: 2240
    Partnering in Research: Maximizing Benefits & Minimizing Risks in Patient-Researcher Relationships
  • Abstract Number: 1678
    Pathogenic Mechanisms of Esophageal Peristaltic Dysfunction By High Resolution Manometry in Patients with Systemic Sclerosis
  • Abstract Number: 2995
    Pathogens in the Inflammatory Process of Periodontal Disease and Juvenile Idiopathic Arthritis
  • Abstract Number: 2639
    Pathological Relevance of T Follicular Helper Cell and Plasmablast in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2815
    Pathological Roles By Siglec and Type I Interferons for the Development of Autoimmune Congenital Heart Block
  • Abstract Number: 2997
    Patient and Family Reported Psychosocial Areas of Concern within Pediatric Rheumatology: Quality Improvement Data and Implications for Practice
  • Abstract Number: 2553
    Patient and Physician Global Assessment Are Poorly Inter-Connected and Poorly Explained By Other Clinical Markers of Disease Activity in Individual Patients with Psoriatic Arthritis
  • Abstract Number: 1856
    Patient and Physician Perspectives on Content Value for Educational Material Regarding Rare Rheumatic Diseases
  • Abstract Number: 196
    Patient Assistance Program Outcomes in a Community Clinic Setting
  • Abstract Number: 2782
    Patient Beliefs and Preference to Initiate a Proposed Medication in Rheumatoid Arthritis
  • Abstract Number: 1192
    Patient Characteristics That Predict the Effect of Laparoscopic Adjustable Gastric Band Weight Loss Surgery on Knee Osteoarthritis Pain
  • Abstract Number: 1393
    Patient Characteristics, Treatment Strategy or Investigator Effect: An Analysis of Factors Driving Variation in Outcomes in Early Rheumatoid Arthritis
  • Abstract Number: 192
    Patient Education Materials in Rheumatology: Only Adequate at Best
  • Abstract Number: 353
    Patient Experiences of Rheumatoid Arthritis Models of Care: An International Survey
  • Abstract Number: 1273
    Patient Health Questionnaire-9 Utilization for the Detection of Depression in Adolescents and Young Adults with Lupus Nephritis
  • Abstract Number: 2266
    Patient Knowledge, Attitudes, and Beliefs Regarding Biologic Therapies in Ankylosing Spondylitis (AS): Insights from a Large-Scale Analysis of Social Media Platforms
  • Abstract Number: 2030
    Patient Motivation in Inflammatory Arthritis: The Use of Ultrasound-Guided Patient Education to Endorse Medication Adherence and Facilitate Cost-Effective Targeted Management
  • Abstract Number: 2535
    Patient Outcomes from a Tertiary Center Combined Rheumatology-Dermatology Clinic
  • Abstract Number: 2268
    Patient Perspectives from a Qualitative Study Predict Non-Adherence in Rheumatoid Arthritis
  • Abstract Number: 1246
    Patient Preferences Associated with the Use of Treatments for Psoriatic Arthritis: Results of a Conjoint Analysis
  • Abstract Number: 1536
    Patient Preferences in Medication for Treatment of Spondyloarthritis: A Qualitative Study
  • Abstract Number: 1253
    Patient Reported Outcomes Explain the Lack of Agreement between Physician and Patient Perceived Remission in Early Rheumatoid Arthritis
  • Abstract Number: 1395
    Patient Reported Outcomes in Rheumatoid Arthritis: Best Domain, Best Interface
  • Abstract Number: 143
    Patient Rheumatoid Arthritis Data from the Real World (PARADE) Study: Preliminary Results from an Apple Researchkit™ Mobile App-Based Real World Study in the United States
  • Abstract Number: 1299
    Patient-Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis
  • Abstract Number: 337
    Patient-Reported Flares Were Correctly Predicted By an Algorithm Using Machine-Learning Statistics on Activity Tracker Data on Steps, in a Longitudinal 3-Month Study of 170 Patients with Rheumatoid Arthritis (RA) or Axial Spondyloarthritis (axSpA)
  • Abstract Number: 1804
    Patient-Reported Outcomes and Damage Predict Mortality in Lupus
  • Abstract Number: 1477
    Patient-Reported Outcomes As Independent Measures of Treatment Success with Sirukumab, an Anti-IL6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis: Post-Hoc Analysis of 2 Placebo-Controlled Phase 3 Trials
  • Abstract Number: 2460
    Patient-Reported Outcomes Following Discontinuation of Methotrexate in Patients with Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab: Results from a Randomized Controlled Trial
  • Abstract Number: 501
    Patient-Reported Outcomes of Long-Term Upadacitinib Use in Patients with Rheumatoid Arthritis: Interim Analysis Results of a Phase 2, Open-Label Extension Study
  • Abstract Number: 336
    Patient–Reported Barriers to Achieving Rheumatoid Arthritis Disease Control
  • Abstract Number: 2253
    Patient’s Self-Monitoring of Disease Activity of Rheumatic Diseases Via Webapp – Study Design, Patient’s Perspective and Recruitment in the First 16 Months of a Swiss Multicentre, Longitudinal Study
  • Abstract Number: 358
    Patients and Physicians Have Different Perceptions of the Relative Bother of the Symptoms and Impacts on Daily Activities in Psoriasis and Psoriatic Arthritis
  • Abstract Number: 152
    Patients Failing to Fulfill 2016 Criteria for Fibromyalgia Represent a Truly Different Population Subset
  • Abstract Number: 2423
    Patients with Active Rheumatoid Arthritis but Normal Levels of Acute Phase Proteins Have Altered Regulatory T Cell Function and Rapidly Progress to Biological Therapies
  • Abstract Number: 1522
    Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis
  • Abstract Number: 2084
    Patients with Early Onset Gout Develop Earlier Severe Joint Involvement  and Metabolic Comorbid Conditions
  • Abstract Number: 350
    Patients with Gout Consider Zero Flares over the Previous Six or Twelve Months Necessary for a Remission State
  • Abstract Number: 120
    Patients with Rheumatoid Arthritis Have Higher Lifetime Professional and Non-Professional Exposure to Silica Dust Particles Compared to General Population
  • Abstract Number: 2633
    Patients with Secondary Sjögren’s Syndrome to SLE Are Characterized By Typical Autoantibodies and a Pro-Inflammatory State
  • Abstract Number: 339
    Patients’ Attitudes and Experiences of Transitional Care in Paediatric Rheumatology: A Systematic Review of Qualitative Studies
  • Abstract Number: 362
    Patients’ Experiences and Attitudes about Non-Medical Switching of Biologics: Results from an Online Patient Survey
  • Abstract Number: 2242
    Pattern and Influential Factors in Promoting Treat-to-Target (T2T) for Follow-up RA Patients with a Rheumatologist-Patient Interactive Smart System of Disease Management (SSDM): A Cohort Study from China
  • Abstract Number: 2944
    Patterns and Characteristics of Accelerated Hand Osteoarthritis: Data from the Osteoarthritis Initiative
  • Abstract Number: 2241
    Patterns and Outcomes on Disease Activity in Patients with Ankylosing Spondylitis (AS) Using Smart System of Disease Management (SSDM): Analysis of T2T Pattern Shift and Influential Factors
  • Abstract Number: 1829
    Patterns and Predictors of Progression of Sacroiliitis in Psoriatic Arthritis and Its Relationship with Human Leukocyte Antigen (HLA) Alleles. Results from the Toronto Cohort
  • Abstract Number: 2281
    Patterns of Medication Use in Non-Systemic Polyarthritis: Data from the Childhood Arthritis and Rheumatology Research Alliance Patient Registry
  • Abstract Number: 1815
    Patterns of Methotrexate Use and Discontinuation in a U.S. Rheumatoid Arthritis Registry
  • Abstract Number: 224
    Patterns of Methotrexate Use in African Countries with Low Versus Medium/High Human Development Index: Preliminary Results of Semi-Structured Interviews
  • Abstract Number: 1883
    Patterns of Osteoarticular Involvement in SAPHO Syndrome: A Cluster Analysis Based on Whole Body Bone Scintigraphy in 157 Patients
  • Abstract Number: 1423
    Patterns of Prednisone Use in US Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine Clinical Practice
  • Abstract Number: 2320
    Pediatric Rheumatology Infusion Center: Report on Therapeutic Protocols and Infusion Reactions over 4 Years
  • Abstract Number: 93
    Peer-Developed E-Learning Resource Can Address Rheumatology Knowledge Gaps in Junior Learners
  • Abstract Number: 2672
    Perceived Barriers to Mental Health Care Among Patients with Systemic Sclerosis: A Qualitative Study
  • Abstract Number: 1235
    Perceived Stress and Fatigue in Systemic Lupus Erythematosus
  • Abstract Number: 213
    Perception of Access to Mental Health Services in Publicly Insured Vs Privately Insured Patients with Rheumatic Diseases
  • Abstract Number: 355
    Perceptions and Outcomes of Pregnancy and Lactation in Patients with Rheumatic Diseases
  • Abstract Number: 1040
    Perceptions of US Community Rheumatologists on Biosimilars
  • Abstract Number: 2056
    Performance and Validity of Musculoskeletal Ultrasound in the Assessment of Synovial Inflammation in Experimental Acute Gout
  • Abstract Number: 147
    Performance of Cardiovascular Risk Age and Vascular Age Estimations in Predicting Cardiovascular Events in Rheumatoid Arthritis
  • Abstract Number: 1696
    Performance of Forced Vital Capacity and Lung Diffusion Cut-Points for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis
  • Abstract Number: 1286
    Performance of Juvenile Scleroderma Classification Criteria for Juvenile Systemic Sclerosis. Results from the Jssc Inception Cohort
  • Abstract Number: 2890
    Performance of Machine Learning Methods Using Electronic Medical Records to Predict Varicella Zoster Virus Infection
  • Abstract Number: 559
    Performance of Multiple Platforms for Autoantibody Testing in Sjogren’s Syndrome
  • Abstract Number: 2694
    Performance of Patient-Reported Outcomes Measurement Information Systems (PROMIS) Promis-29 and Promis Self-Efficacy in Systemic Sclerosis (SSc)
  • Abstract Number: 726
    Performance of the American College of Rheumatology Provisional Composite Response Index in Systemic Sclerosis (CRISS) in the Scleroderma Lung Study-I
  • Abstract Number: 1806
    Performance of the Brief Index of Lupus Damage (BILD) in a Multi-Ethnic Population-Based Systemic Lupus Erythematosus (SLE) Cohort
  • Abstract Number: 830
    Performance on Quality Measures in the RISE Registry and the Merit-Based Incentive Payment System (MIPS)
  • Abstract Number: 1457
    Perioperative Management of Methotrexate and Tumor Necrosis Factor Inhibitor Combination Therapy in Rheumatoid Arthritis Patients
  • Abstract Number: 1332
    Periostin Deficiency Exacerbates Joint Inflammation and Bone Destruction in Mouse Models of Rheumatoid Arthritis
  • Abstract Number: 1401
    Persistence of Mast Cell-Rich Synovitis Is Associated with Lack of Response to Synthetic Disease Modifying Anti-Rheumatic Drugs in Patients with Early Rheumatoid Arthritis
  • Abstract Number: 953
    Persistence of Pathogenic CD4 Memory T Cells Revealed through Cytometry Time of Flight in Juvenile Idiopathic Arthritic Patients with Disease Resurgence upon Withdrawal of Anti-TNFA Biologics
  • Abstract Number: 1001
    Persistence, Discontinuation, and Switching Patterns Among Ankylosing Spondylitis Patients Newly Initiating Biologic Therapy
  • Abstract Number: 1552
    Persistency of Tumor Necrosis Factor Inhibitor Therapy in US Patients with Ankylosing Spondylitis: Data from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
  • Abstract Number: 1890
    Persistent Fracture Reduction with Abaloparatide-SC (TYMLOS™) Followed By 24 Months of Alendronate
  • Abstract Number: 2892
    Persistently Frequent Emergency Department (ED) Utilization Among Systemic Lupus Erythematosus (SLE) Patients 
  • Abstract Number: 1259
    Perspectives of Young People with Juvenile Idiopathic Arthritis, Their Caregivers, and Health Care Providers on Transition to Adult Care: Informing Development of a Transition Toolkit
  • Abstract Number: 915
    Pesticide Exposure and Risk of Systemic Lupus Erythematosus in an Urban Population of Predominantly African-American Women
  • Abstract Number: 801
    PET-CT Findings and Clinical Outcomes in Takayasu Arteritis – Does 18F-Fluorodeoxyglucose Uptake in Arteries Predict Relapses?
  • Abstract Number: 2868
    Pharmacodynamic Analysis of Whole Blood Gene Expression over 2 Years in a Phase IIIb Head-to-Head Trial of Abatacept and Adalimumab in Patients with RA
  • Abstract Number: 2565
    Pharmacodynamic Modeling of BTK Occupancy Versus Efficacy in Ra and SLE Models Using the Novel Specific BTK Inhibitor Evobrutinib
  • Abstract Number: 1893
    Pharmacokinetics (PK), Pharmacodynamics (PD), and Proposed Dosing of Oral Janus Kinase (JAK)1 and JAK2 Inhibitor Baricitinib in Patients with IFN-Mediated Autoinflammatory Diseases (AIDs)
  • Abstract Number: 1752
    Pharmacokinetics of Rituximab and Clinical Outcomes in Patients with ANCA-Associated Vasculitis
  • Abstract Number: 395
    Pharmacological and Safety Profiles of Cyclin-Dependent Kinase 4/6 Inhibitor, Candidate for Development As Rheumatoid Arthritis Therapeutic Option
  • Abstract Number: 210
    Pharmacovigilance Surveillance of Autoimmune Diseases Induced By Biological Agents: A Review of 12013 Cases (aeBIOGEAS-SEMI Registry)
  • Abstract Number: 888
    Phase 3 Trial Results with Blisibimod, a Selective Inhibitor of B-Cell Activating Factor, in Subjects with Moderate-to-Severe Systemic Lupus Erythematosus
  • Abstract Number: 1514
    Phenotype Differences in HLA-B27 Positive Versus Negative Patients with Ankylosing Spondylitis in a Population That Show Relatively Weaker Association with HLA-B27
  • Abstract Number: 372
    Phenotype of Chronic Recurrent Multifocal Osteomyelitis in a Tertiary Referral Centre: The Great Ormond Street Hospital Experience
  • Abstract Number: 1070
    Phenotypic Characterization of Peripheral Basophil Perturbations in the Antiphospholipid Syndrome
  • Abstract Number: 1167
    Phenotypical Features of Patients with Rheumatologic Manifestations of Common Variable Immunodeficiency
  • Abstract Number: 396
    Phospho-STAT1 Inhibition Is the Initial Step after Tofacitinib Treatment in Rabbits with Severe Chronic Synovitis
  • Abstract Number: 1209
    Phospholipase A2 Group 5 Is a Potential Therapeutic Target for Osteoarthritis Treatment
  • Abstract Number: 2193
    Physical Activity and Disease Progression in Persons with or at Higher Risk for Knee Osteoarthritis
  • Abstract Number: 2766
    Physical Therapy Vs. Internet-Based Exercise Training for Patients with Knee Osteoarthritis: Results of a Randomized Controlled Trial
  • Abstract Number: 2013
    Physician Experience and Patient´s Disease Activity Affect the Impact of Musculoskeletal Ultrasound on the Treatment Decision in Rheumatoid Arthritis Patients
  • Abstract Number: 1384
    Physician Global Assessments for Disease Activity in Rheumatoid Arthritis Are All over the Map!
  • Abstract Number: 84
    Physiological Autoantibodies Against the Endthelin Receptor Type-a Are Critically Involved in the Homeostasis of Immune Cells
  • Abstract Number: 2092
    Pilot Clinical Study of a Novel Unobtrusive Carpal Tunnel Tissue Manipulation Device in Reducing Symptoms of Carpal Tunnel Syndrome
  • Abstract Number: 1781
    Pituitary Disease and Granulomatosis with Polyangiitis: A Collaborative Canadian Case Series and Review of the Literature
  • Abstract Number: 2708
    Placental Growth Factor Regulates the Generation of T-Helper 17 Cells to Link Angiogenesis with Autoimmunity
  • Abstract Number: 2600
    Plasma Cell and T-Cell Activity Downregulation during MMF Therapy in SLE May be Necessary for Successful Immunosuppression
  • Abstract Number: 1281
    Plasma CXCL4 As a Biomarker in Juvenile Systemic Sclerosis
  • Abstract Number: 466
    Plasma Cytokines at Diagnosis May Predict Non-Response to Methotrexate in Patients with Early Rheumatoid Arthritis
  • Abstract Number: 2690
    Plasma D-Dimer Levels Are More Frequently Elevated in Limited Than Diffuse Cutaneous Systemic Sclerosis but Do Not Reflect Disease Duration or Vasculopathy
  • Abstract Number: 2338
    Plasma Exosomes from Children with Juvenile Dermatomyositis Are Taken up By Human Aortic Endothelial Cells and Are Associated with Altered Gene Expression in Those Cells
  • Abstract Number: 757
    Plasmacytoid Dendritic Cells Activated through TLR8 Promote Systemic Sclerosis
  • Abstract Number: 2776
    Plasmacytoid Dendritic Cells in Systemic Fibrosis: Pathogenic Role in Bleomycin-Induced Fibrosis Model and Correlation with Disease in Patients with Systemic Sclerosis
  • Abstract Number: 77
    Platelets Induce IL-1b Production in Human Monocytes through NLRP3 Inflammasome Activation
  • Abstract Number: 2606
    Pneumococcal Vaccination in Patients with Systemic Lupus Erythematosus: A Multicenter Placebo-Controlled Randomized Double-Blind Study
  • Abstract Number: 2026
    Pneumococcal Vaccination Rates: Improving Safety in Immunocompromised Patients
  • Abstract Number: 53
    Poly-γ-Glutamic Acid Inhibits RANKL- Induced Osteoclast Differentiation and Prevents Bone Destruction in Rheumatoid Arthritis: Human and CIA Mouse Model
  • Abstract Number: 1303
    Polycystic Ovarian Syndrome in Rheumatic Disease
  • Abstract Number: 2365
    Poor Cardiovascular Risk Management in Rheumatoid Arthritis Patients Despite an Explicit Cardiovascular Risk Management Program
  • Abstract Number: 122
    Poor Prognostic Factors at the Start of Methotrexate Therapy Are Not Associated with Worse Treatment Response: Results from the Rheumatoid Arthritis Medication Study
  • Abstract Number: 2061
    Population-Specific Factors Associated with Fractional Excretion of Uric Acid
  • Abstract Number: 702
    Positive Direct Coombs’ Test in the Absence of Hemolytic Anemia Predicts High Disease Activity and Poor Renal Response in Systemic Lupus Erythematosus
  • Abstract Number: 11
    Possible Therapeutics for Antiphospholipid Antibody Related Thrombocytopenia: A Systemic Review and Meta-Analysis
  • Abstract Number: 431
    Post-Marketing Surveillance of Tofacitinib in Japanese Patients with Rheumatoid Arthritis: An Interim Report of Safety Data
  • Abstract Number: 1228
    Postmenopausal Breast Cancer Patients on Aromatase Inhibitor Therapy and Their Increased Risk of Fragility Fracture
  • Abstract Number: 2025
    Potential Clinical Utility of Manu-Scan, the Novel Optical Molecular Imaging, in Patients with Hand Rheumatoid Arthritis
  • Abstract Number: 2501
    Potential Differences in Axial Spondyloarthritis Disease Activity Categorization Using Different Minimum Values for High-Sensitivity CRP in Ankylosing Spondylitis Disease Activity Score Calculation and Different Definitions of Disease Flare
  • Abstract Number: 238
    Power Dopper Ultrasonography Detects Superior Efficacy of Non-TNF Biologics Compared to Cycling of TNF Inhibitors in RA Patients Inadequate Response to First TNF Inhibitors
  • Abstract Number: 2041
    Practice Improvement Utilizing Six Sigma and Health Informatics in an Academic Setting
  • Abstract Number: 2839
    Practice Patterns of Pneumocystis Pneumonia Prophylaxis in Connective Tissue Diseases:  a Survey of Infectious Disease Physicians
  • Abstract Number: 790
    Pre-Clinical Evidences of Immunomodulatory Activities of Tuftsin-Phosphorylcholine on Samples from Patients with Giant Cell Arteritis in Comparison to Corticosteroids
  • Abstract Number: 2881
    Pre-Existing Psoriasis Is Predictive for Clinical Relapse after Drug-Free Remission Induced By Therapy with Golimumab in Early Peripheral Spondyloarthritis
  • Abstract Number: 2027
    Pre-Visit Planning Improves Pneumococcal Vaccination in Patients with Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 175
    Precisely Controlled Differential Gene Expression System to Investigate the Effect of eQTL
  • Abstract Number: 2625
    Predicting Flares in Patients with Stable Systemic Lupus Erythematosus
  • Abstract Number: 448
    Predicting Remission at 6 Months in Early Rheumatoid Arthritis Treated with Conventional Synthetic Dmards
  • Abstract Number: 1213
    Prediction Model for the Two-Year Risk of Fracture Among Older US Women
  • Abstract Number: 744
    Prediction of All-Cause Mortality and Pulmonary Arterial Hypertension (PAH) Progression in Systemic Sclerosis (SSc), an Echocardiography Study
  • Abstract Number: 138
    Prediction of Cardiovascular Events in Rheumatoid Arthritis Patients Using a Multi-Biomarker of Disease Activity
  • Abstract Number: 2816
    Prediction of Connective Tissue Disease in an at-Risk Cohort Using a Novel Interferon Stimulated Gene Expression Score
  • Abstract Number: 740
    Prediction of Fibrosis Progression in Systemic Sclerosis By Collagen Biomarkers
  • Abstract Number: 731
    Prediction of Progression of Interstitial Lung Disease in Patients with Systemic Sclerosis
  • Abstract Number: 2024
    Prediction of Response to Certolizumab-Pegol in Rheumatoid Arthritis By Functional MRI of the Brain – an Interim Analysis of an Ongoing Investigator Initiated Phase III Trial
  • Abstract Number: 1654
    Predictive Factors According to Type of Infection in Systemic Lupus Erythematosus Patients: Data from a Multi-Ethnic, Multi-National, Latin-American Cohort
  • Abstract Number: 1460
    Predictive Factors Associated with Successful Down-Titration of Biologics for Rheumatoid Arthritis Patients in Clinical Practice
  • Abstract Number: 2138
    Predictive Factors for Achievement of Sustained Remission with Polymyositis/Dermatomyositis: A Retrospective Single Center Cohort Study in Japan
  • Abstract Number: 275
    Predictive Factors of Cytomegalovirus Infection in Patients with Connective Tissue Diseases Treated with Immunosuppressive Drugs
  • Abstract Number: 854
    Predictive Modeling of Mortality in Polymyositis/Dermatomyositis Patients with Interstitial Lung Disease Based on Combination of Serum Myositis-Specific Autoantibodies and Conventional Biomarkers
  • Abstract Number: 7
    Predictive Value for Thrombosis of Double or Triple Positivity in Secondary APS Depends on the Component Assays and the Type of Thrombosis
  • Abstract Number: 2984
    Predictive Value of a Combined Index for Weight Loss in Systemic Sclerosis
  • Abstract Number: 2769
    Predictive Value of Leisure-Time Physical Activity in Women with Systemic Erythematosus Lupus on Physical and Mental Health
  • Abstract Number: 2300
    Predictive Value of Magnetic Resonance Imaging in Patients with Juvenile Idiopathic Arthritis in Clinical Remission
  • Abstract Number: 2073
    Predictors for Clinically Diagnosed Gout – Results from 30 Years Follow-up of the Malmö Preventive Project Cohort in Southern Sweden
  • Abstract Number: 2983
    Predictors for Disease Worsening Defined By Organ Failure in Diffuse Systemic Sclerosis: A European Scleroderma Trials and Research (EUSTAR) Analysis
  • Abstract Number: 1306
    Predictors of Contraceptive Use Among Reproductive-Age Women with Rheumatic Diseases
  • Abstract Number: 433
    Predictors of Earlier Biologic Initiation Among Patients with Rheumatoid Arthritis Starting Methotrexate
  • Abstract Number: 2895
    Predictors of Hospitalization, Length of Stay and Costs of Care Among Children with Juvenile Dermatomyositis in the United States
  • Abstract Number: 1560
    Predictors of Long-Term Modified Minimal Disease Activity Response in Peripheral Spondyloarthritis Patients Treated with Adalimumab
  • Abstract Number: 631
    Predictors of Long-Term Retention of Methotrexate and Other Dmards with Golimumab in Rheumatoid Arthritis and Psoriatic Arthritis: An Analysis from a Prospective, Observational Registry
  • Abstract Number: 524
    Predictors of Mortality in RA Patients before Biologic Therapy
  • Abstract Number: 2803
    Predictors of Remission Maintenance up to Week 68 and Successful Therapy Discontinuation in Patients with Non-Radiographic Axial Spondyloarthritis Who Achieved Sustained Remission on 28-Week Open-Label Adalimumab Treatment
  • Abstract Number: 1812
    Preeclampsia and Incident Cardiovascular Disease in SLE Pregnancy
  • Abstract Number: 2780
    Preference Phenotypes Can be Used to Support Shared Decision Making at the Point-of-Care
  • Abstract Number: 349
    Preferences and Satisfaction in a Pediatric Multidisciplinary Infusion Center
  • Abstract Number: 2251
    Preferences for Physical Activity: A Discrete Choice Experiment in People with Chronic Knee Pain
  • Abstract Number: 6
    Pregnancy  Outcomes in a Cohort of Women with Antiphospholipid Syndrome. 25- Years  Long-Term Observation 
  • Abstract Number: 1311
    Pregnancy Outcome in Chinese Women with Rheumatic Disease Treated By Leflunomide (LEF)
  • Abstract Number: 1295
    Pregnancy Outcome in Patients with SLE Compared to Patients with Other Inflammatory Rheumatic Diseases: Real World Data from a Prospective Pregnancy Register
  • Abstract Number: 1312
    Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis; Hur-BIO Real Life Experiences
  • Abstract Number: 2804
    Pregnancy Outcomes in Patients with Ankylosing Spondylitis: A Nationwide Population Study
  • Abstract Number: 1314
    Pregnancy Outcomes in Patients with Psoriasis: A Nationwide Population-Based Study
  • Abstract Number: 2823
    Preliminary Comparison of Patient-Centered Weight Loss Programs Starting before Versus after Knee Replacement
  • Abstract Number: 1482
    Preliminary Population-Based Incidence and Prevalence Estimates of Primary Sjogren’s Syndrome from the Manhattan Lupus Surveillance Program
  • Abstract Number: 356
    Preliminary Real World Data on Switching Patterns between Etanercept, Its Recently Marketed Biosimilar Counterpart and Its Competitor Adalimumab, Using Swedish Prescription Registry
  • Abstract Number: 2877
    Premature Senescence of Naive CD4+ T-Cells in Primary Sjogren’s Syndrome
  • Abstract Number: 2646
    Premature Senescence of Naive CD4+ T-Cells in Systemic Lupus Erythematosus
  • Abstract Number: 1034
    Presence of Anti-Cyclic Citrullinated Peptide Antibodies Is Associated with Better Treatment Response to Abatacept but Not to TNF Inhibitors in Patients with RA: A Meta-Analysis
  • Abstract Number: 253
    Presence of Bone Marrow Edema and Structural Lesions on Magnetic Resonance Imaging of the Sacroiliac Joints in Young Military Recruits before and after 6 Weeks of Intensive Physical Training
  • Abstract Number: 608
    Presence of Poor Prognostic Factors May Predict Response to Abatacept in Patients with Active Psoriatic Arthritis: Results from a Post Hoc Analysis from a Phase III Study
  • Abstract Number: 796
    Presentation and Outcome of Large-Vessel Vasculitis Diagnosed between 50 and 60 Years: Case-Control Study Based on 183 Cases
  • Abstract Number: 1290
    Preterm Birth Phenotypes in Women with Autoimmune Diseases
  • Abstract Number: 1291
    Preterm Delivery Phenotypes in SLE Pregnancies
  • Abstract Number: 809
    Prevalence and Distribution of Vascular FDG Uptake on Positron Emission Tomography (PET)-CT in Patients Suspected of Having Giant Cell Arteritis – Interim Results from the Giant Cell Arteritis and PET Scan (GAPS) Study
  • Abstract Number: 266
    Prevalence and Pattern of Hand Osteoarthritis in a Working Population Using Ultrasound
  • Abstract Number: 1969
    Prevalence and Predictive Value over 16 Years of Serum Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibodies in the General Population
  • Abstract Number: 1595
    Prevalence and Predictors of Depression in Patients with Systemic Lupus Erythematosus: Results from the Korean Lupus Network (KORNET) Registry
  • Abstract Number: 1050
    Prevalence and Predictors of Knee Replacement Overuse and Underuse in the US
  • Abstract Number: 1771
    Prevalence and Prognostic Relevance of Cardiovascular Involvement in ANCA-Associated Vasculitis: A Retrospective Cohort Study
  • Abstract Number: 2515
    Prevalence and Risk Factors for Osteoporotic Fractures and Low Bone Mineral Density in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis
  • Abstract Number: 711
    Prevalence and Risk Factors of Depressive Disorders in Chinese Patients with Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 2510
    Prevalence of and Factors Associated with Sarcopenia in Patients of Ankylosing Spondylitis
  • Abstract Number: 8L
    Prevalence of Blindness in a Cohort of Rheumatologic Patients Treated with Hydroxychloroquine
  • Abstract Number: 2883
    Prevalence of Cardiovascular Risk Factors and Subclinical Cardovacular Disease in Psoriatic Arthritis
  • Abstract Number: 1122
    Prevalence of Chronic Kidney Disease and Uncontrolled Serum Uric Acid Levels in US Adult Gout Population: Results from the National Health and Nutrition Examination Survey 2007–2012
  • Abstract Number: 1623
    Prevalence of Cognitive Impairment in Systemic Lupus Erythematosus Assessed By a Comprehensive Neuropsychological Battery
  • Abstract Number: 1621
    Prevalence of Cognitive Impairment in Systemic Lupus Erythematosus Assessed By the Automated Neuropsychological Assessment Metrics
  • Abstract Number: 2528
    Prevalence of Depression and Attention Deficit Hyperactivity Disorder in Female Patients at a Combined Psoriasis-Psoriatic Arthritis Center
  • Abstract Number: 258
    Prevalence of Echocardiographic Findings in Connective Tissue Diseases – a Retrospective Cohort Study
  • Abstract Number: 151
    Prevalence of Fibromyalgia in Nurses; A Cross Sectional Study
  • Abstract Number: 153
    Prevalence of Fibromyalgia in Physician in Training; A Cross Sectional Study
  • Abstract Number: 2387
    Prevalence of Hepatitis C Virus Infection in Egyptian Patients with Rheumatoid Arthritis
  • Abstract Number: 2001
    Prevalence of Inflammatory Posterior Arch Abnormalities on Lumbar Spine MRI in Spondyloarthritis Patients Compared to Low Back Pain Patients
  • Abstract Number: 924
    Prevalence of Juvenile Idiopathic Arthritis in the Alaska Native Population
  • Abstract Number: 523
    Prevalence of Occult Hepatitis B Carrier Status and Its Associated Risk Factors in Patients with Rheumatic Diseases Undergoing Biological Therapies
  • Abstract Number: 2094
    Prevalence of Organ Involvement in Mixed Connective Tissue Disease
  • Abstract Number: 269
    Prevalence of Pneumococcal Vaccination in Rheumatologic Patients with Community Acquired Pneumonia. Biobadasar Registry
  • Abstract Number: 787
    Prevalence of Relapses of Giant Cell Arteritis in Patients Treated with Corticosteroids: A Meta-Analysis
  • Abstract Number: 136
    Prevalence of Rheumatoid Arthritis and Associated Comorbidities in the 2011-2015 Medicare Population
  • Abstract Number: 2312
    Prevalence of Serum 14-3-3η (eta) in Juvenile Idiopathic Arthritis
  • Abstract Number: 2745
    Prevalence of Vasculitides As Extraintestinal Manifestation of Inflammatory Bowel Disease (IBD)
  • Abstract Number: 2778
    Preventing Rheumatoid Arthritis: North American Perspectives of Patients and First-Degree Relatives on the Risk of Developing the Disease and of Potential Preventative Interventions
  • Abstract Number: 2068
    Previous Prescription of Allopurinol Reduces the Risk of Nsaids-Related Acute Kidney Injury in Patients with Gout
  • Abstract Number: 1612
    Primary Respiratory Disease in Patients with Systemic Lupus Erythematosus: Data from the Spanish Rheumatology Society Lupus Registry (RELESSER) Cohort
  • Abstract Number: 2103
    Problems in the Diagnosis of Familial Mediterranean Fever in Turkey
  • Abstract Number: 2313
    Procalcitonin Differentiates Infection from Active Disease in Patients with Juvenile Idiopathic Arthritis
  • Abstract Number: 197
    Process Evaluation of the Making It Work Program, an Online Program to Help People with Inflammatory Arthritis Remain Employed
  • Abstract Number: 80
    Production and Characterization of Human Interferon-Epsilon and Interferon-Kappa to Investigate Their Potential Role in Lupus
  • Abstract Number: 1780
    Prognostic Factors in Patients with Granulomatosis with Polyangiitis Requiring Hospitalization- a 10 Year Nationwide Analysis
  • Abstract Number: 2164
    Prognostic Factors in Polymyositis/ Dermatomyositis Patients with Anti-Synthetase Antibodies
  • Abstract Number: 554
    Prognostic Significance of Double Positive Anti Ro/SS-a and La/SS-B Antibodies in Patients with Primary Sjogren’s Syndrome: Prospective Salivary Gland Ultrasound Study
  • Abstract Number: 820
    Prognostic Value of Positron Emission Tomography in a Prospective, Longitudinal Cohort of Patients with Large Vessel Vasculitis
  • Abstract Number: 732
    Progression of Skin Fibrosis Is Associated with Decline in Lung Function in Patients with Diffuse Cutaneous Systemic Sclerosis: A European Scleroderma Trials and Research (EUSTAR) Analysis
  • Abstract Number: 593
    Progression of Structural Damage on MRI in Patients with Axial Spondyloarthritis Is Limited: The 5 –Year Results in the DESIR Cohort
  • Abstract Number: 1660
    Prolactin Induces an Interferon Signature in Monocytes and Drives IRF1-HAT Interactions
  • Abstract Number: 1590
    Prolonged Antimalarial Treatment Increases the Risk for Severe Brady-Arrhythmias in Systemic Lupus Erythematosus
  • Abstract Number: 714
    Prolonged Antimalarial Treatment Is Associated with Increased Risk for Elevated Myocardial Biomarkers in Systemic Lupus Erythematosus
  • Abstract Number: 716
    Prolonged Exposure to Antiphospholipid Antibodies Is Associated with Endothelial Dysfunction in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2568
    Prophylactic and Therapeutic Administration of a JAK1-Selective Inhibitor Blocks and Reverses Nephritis and Sialadenitis in NZB/W-F1 Mice
  • Abstract Number: 1778
    Prophylactic Treatment and Incidence of Pneumocystis Jirovecci Pneumonia in Japanese Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
  • Abstract Number: 2045
    Prophylaxis of Ischemic Disease in Giant Cell Arteritis Patients: An Application of a “Big Data” Tracking Tool in the Electronic Health Record in an University-Based Medical Center
  • Abstract Number: 917
    Prospective Association of Metabolic Syndrome with Incident Symptomatic Interphalangeal Osteoarthritis but Not Thumb Based or Erosive Hand Osteoarthritis
  • Abstract Number: 2017
    Prospective Study of Bio-Free Remission Maintenance Using Ultrasonography in Rheumatoid Arthritis Patients: 52-Week Result
  • Abstract Number: 2311
    Prospective Validation of the Juvenile Spondyloarthritis Disease Activity Index and Its Comparison with Adult Spondyloarthritis Disease Activity Scores
  • Abstract Number: 738
    Prospective Validation of the Systemic Sclerosis Skin Symptoms Patient-Reported Outcome (SSPRO) in a Phase 2 Trial of Anabasum (JBT-101) in Diffuse Cutaneous Systemic Sclerosis (dcSSc)
  • Abstract Number: 1448
    Prospective, Intervention, Multicenter, Non-Inferiority Study of Utility of Therapeutic Drug Monitoring with Respect to the Efficacy and Cost of Adalimumab Tapering in Patients with Rheumatic Diseases
  • Abstract Number: 656
    Prostaglandin E2 and Its Receptor Subtype EP4 Are Involved in Ankylosing Spondylitis Disease Progression
  • Abstract Number: 384
    Protection Against Hepatitis B in Immunocompromised Pediatric Rheumatology and Gastroenterology Patients
  • Abstract Number: 1111
    Protective Effect of Allopurinol Use on Kidney Function Among Patients with Gout and Chronic Kidney Disease
  • Abstract Number: 39
    Protein Array Technology Identifies Rituximab-Treated Non-Responder Rheumatoid Arthritis Patients to Generate New Autoantibody Repertoires during Treatment
  • Abstract Number: 479
    Protein Carbamylation Is Induced By Activated Neutrophil: Ex Vivo Analysis
  • Abstract Number: 1411
    Protein Tyrosine Phosphatase Non-Receptor 22 / C-Src Tyrosine Kinase Complex Down-Regulated in Patients with Rheumatoid Arthritis
  • Abstract Number: 2123
    Protein-Losing Enteropathy in Patients with Systemic Autoimmune Diseases: Characterization of 263 Cases (GEAS-SEMI Spanish Cohort)
  • Abstract Number: 769
    Proteomic Analysis of Human Fibroblasts in Systemic Sclerosis Reinforces the Role of Transforming Growth Factor-ß and Points Toward Epidermal Growth Factor Receptor / Phosphatidylinositol 3 Kinase Pathway Inhibition
  • Abstract Number: 765
    Proteomic Analysis of Scleroderma Associated Joint Disease
  • Abstract Number: 2626
    Proton Pump Inhibitor Induced Subacute Cutaneous Lupus Erythematosus: Clinical Characteristics and Outcomes
  • Abstract Number: 2060
    Pseudogout Among Patients Fulfilling a Billing Code Algorithm for Calcium Pyrophosphate Deposition Disease (CPPD)
  • Abstract Number: 2544
    Psoriatic Arthritis Impact of Disease (PSAID12) in Early Psoriatic Arthritis: Pain As One of the Main Determinants of Disease Impact
  • Abstract Number: 335
    Psoriatic Arthritis Patients Who Attain a Very Low Disease Activity State Have a Minimal Impact of the Disease on Their Lives
  • Abstract Number: 254
    Psoriatic Arthritis Sonographic Enthesitis Scores – Systematic Review of the Literature
  • Abstract Number: 1807
    Psychometric Evaluation of the Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ) in Inflammatory Arthritis
  • Abstract Number: 352
    Psychometric Features of a New Methotrexate (MTX)-Specific Adherence Tool for Use in the Management of Patients with Rheumatoid Arthritis (RA): Preliminary Results from an Online Patient Community
  • Abstract Number: 1062
    Ptpn22 Regulates Synovial Slam Family Receptor Expression during Toll-like Receptor-Driven Suppression of Inflammatory Arthritis
  • Abstract Number: 991
    Publication Timeliness of the Randomized Controlled Trials of Drug Therapy for Inflammatory Arthritis
  • Abstract Number: 529
    Pulmonary Involvement in Our Patients with Rheumatoid Arthritis Under Biological Therapy: A Tertiary Hospital Experience
  • Abstract Number: 1760
    Pulmonary Manifestations in Microscopic Polyangiitis and Granulomatosis with Polyangiitis: A Multicenter Cohort Analysis
  • Abstract Number: 2737
    Pulmonary Manifestations of Primary Systemic Vasculitides
Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences